CHI3L2 as A Potential Drug Target Or Biomarker for Neurological Disorders

Target Name: CHI3L2

NCBI ID: G1117

CHI3L2

CHI3L2 as A Potential Drug Target Or Biomarker for Neurological Disorders

CHI3L2 (CHI3L2 variant 1) is a protein that is expressed in various tissues of the body, including the brain, spinal cord, and peripheral nerves. It is a member of the CHI3L family, which includes several related proteins that are involved in the regulation of cellular processes such as inflammation and neurotransmitter signaling.

Recent studies have identified CHI3L2 as a potential drug target or biomarker for a variety of neurological and psychiatric disorders, including multiple sclerosis, Alzheimer's disease, and depression. This is because CHI3L2 has been shown to play a role in the regulation of neuroinflammation, which is the inflammation that occurs in the brain in response to injury or infection.

One of the key mechanisms by which CHI3L2 is involved in neuroinflammation is its role in the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1. These cytokines can contribute to the persistent inflammation that is thought to play a role in the development of many neurological disorders, including multiple sclerosis and Alzheimer's disease.

Another way in which CHI3L2 may be involved in neuroinflammation is its role in the regulation of glial cells, which are a type of nerve cell that support the growth and function of neurons. Glial cells are involved in the production of pro-inflammatory cytokines, and have been implicated in the development of neurodegenerative disorders. CHI3L2 has been shown to regulate the activity of glial cells, which may play a role in the regulation of neuroinflammation.

In addition to its role in neuroinflammation, CHI3L2 has also been shown to be involved in the regulation of neurotransmitter signaling. This is thought to be another potential mechanism by which CHI3L2 may be involved in the development of neurological disorders.

The CHI3L2 protein is also a potential biomarker for multiple sclerosis, as high levels of CHI3L2 have been observed in individuals with this disease. Additionally, CHI3L2 has also been shown to be involved in the regulation of pain perception, which may be another potential mechanism by which it could be used as a drug target or biomarker.

Overall, CHI3L2 is a protein that has been identified as having potential as a drug target or biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Chitinase 3 Like 2

Functions: Lectin that binds chitooligosaccharides and other glycans with high affinity, but not heparin. Has no chitinase activity

The "CHI3L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHI3L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets